Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2

The recent emergence of SARS-CoV-2 Omicron variants possessing large numbers of mutations has raised concerns of decreased effectiveness of current vaccines, therapeutic monoclonal antibodies, and antiviral drugs for COVID-19 against these variants1,2. While the original Omicron lineage, BA.1, has b...

Full description

Saved in:
Bibliographic Details
Published inNature
Main Authors Kawaoka, Yoshihiro, Uraki, Ryuta, Kiso, Maki, Iida, Shun, Imai, Masaki, Takashita, Emi, Kuroda, Makoto, Halfmann, Peter, Loeber, Samantha, Maemura, Tadashi, Yamayoshi, Seiya, Fujisaki, Seiichiro, Wang, Zhongde, Ito, Mutsumi, Ujie, Michiko, Iwatsuki-Horimoto, Kiyoko, Furusawa, Yuri, Wright, Ryan, Chong, Zhenlu, Ozono, Seiya, Yasuhara, Atsuhiro, Ueki, Hiroshi, Sakai, Yuko, Li, Rong, Liu, Yanan, Larson, Deanna, Koga, Michiko, Tsutsumi, Takeya, Adachi, Eisuke, Saito, Makoto, Yamamoto, Shinya, Matsubara, Shohei, Hagihara, Masao, Mitamura, Keiko, Sato, Tetsuro, Hojo, Masayuki, Hattori, Shin-Ichiro, Maeda, Kenji, Okuda, Moe, Murakami, Jurika, Duong, Calvin, Godbole, Sucheta, Douek, Daniel, Watanabe, Shinji, Ohmagari, Norio, Yotsuyanagi, Hiroshi, Diamond, Michael, Hasegawa, Hideki, Mitsuya, Hiroaki, Suzuki, Tadaki
Format Journal Article Web Resource
LanguageEnglish
Japanese
Published United States Research Square 24.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The recent emergence of SARS-CoV-2 Omicron variants possessing large numbers of mutations has raised concerns of decreased effectiveness of current vaccines, therapeutic monoclonal antibodies, and antiviral drugs for COVID-19 against these variants1,2. While the original Omicron lineage, BA.1, has become dominant in many countries, BA.2 has been detected in at least 67 countries and has become dominant in the Philippines, India, and Denmark. Here, we evaluated the replicative ability and pathogenicity of an authentic infectious BA.2 isolate in immunocompetent and human ACE2 (hACE2)-expressing mice and hamsters. In contrast to recent data with chimeric, recombinant SARS-CoV-2 strains expressing the spike proteins of BA.1 and BA.2 on an ancestral WK-521 backbone3, we observed similar infectivity and pathogenicity in mice and hamsters between BA.2 and BA.1, and less pathogenicity compared to early SARS-CoV-2 strains. We also observed a marked and significant reduction in the neutralizing activity of plasma from COVID-19 convalescent individuals and vaccine recipients against BA.2 compared to ancestral and Delta variant strains. In addition, we found that some therapeutic monoclonal antibodies (REGN10987/REGN10933, COV2-2196/COV2-2130, and S309) and antiviral drugs (molnupiravir, nirmatrelvir, and S-217622) can restrict viral infection in the respiratory organs of hamsters infected with BA.2. These findings suggest that the replication and pathogenicity of BA.2 is comparable to that of BA.1 in rodents and that several therapeutic monoclonal antibodies and antiviral compounds are effective against Omicron/BA.2 variants.
AbstractList The recent emergence of SARS-CoV-2 Omicron variants possessing large numbers of mutations has raised concerns of decreased effectiveness of current vaccines, therapeutic monoclonal antibodies, and antiviral drugs for COVID-19 against these variants1,2. While the original Omicron lineage, BA.1, has become dominant in many countries, BA.2 has been detected in at least 67 countries and has become dominant in the Philippines, India, and Denmark. Here, we evaluated the replicative ability and pathogenicity of an authentic infectious BA.2 isolate in immunocompetent and human ACE2 (hACE2)-expressing mice and hamsters. In contrast to recent data with chimeric, recombinant SARS-CoV-2 strains expressing the spike proteins of BA.1 and BA.2 on an ancestral WK-521 backbone3, we observed similar infectivity and pathogenicity in mice and hamsters between BA.2 and BA.1, and less pathogenicity compared to early SARS-CoV-2 strains. We also observed a marked and significant reduction in the neutralizing activity of plasma from COVID-19 convalescent individuals and vaccine recipients against BA.2 compared to ancestral and Delta variant strains. In addition, we found that some therapeutic monoclonal antibodies (REGN10987/REGN10933, COV2-2196/COV2-2130, and S309) and antiviral drugs (molnupiravir, nirmatrelvir, and S-217622) can restrict viral infection in the respiratory organs of hamsters infected with BA.2. These findings suggest that the replication and pathogenicity of BA.2 is comparable to that of BA.1 in rodents and that several therapeutic monoclonal antibodies and antiviral compounds are effective against Omicron/BA.2 variants.
Author Koga, Michiko
Mitamura, Keiko
Godbole, Sucheta
Uraki, Ryuta
Hattori, Shin-Ichiro
Adachi, Eisuke
Wright, Ryan
Saito, Makoto
Yamayoshi, Seiya
Ueki, Hiroshi
Iida, Shun
Furusawa, Yuri
Liu, Yanan
Yamamoto, Shinya
Imai, Masaki
Halfmann, Peter
Duong, Calvin
Kuroda, Makoto
Murakami, Jurika
Ujie, Michiko
Yasuhara, Atsuhiro
Fujisaki, Seiichiro
Sakai, Yuko
Ito, Mutsumi
Takashita, Emi
Yotsuyanagi, Hiroshi
Hagihara, Masao
Hojo, Masayuki
Ohmagari, Norio
Maeda, Kenji
Sato, Tetsuro
Matsubara, Shohei
Chong, Zhenlu
Diamond, Michael
Loeber, Samantha
Li, Rong
Suzuki, Tadaki
Watanabe, Shinji
Okuda, Moe
Iwatsuki-Horimoto, Kiyoko
Mitsuya, Hiroaki
Kiso, Maki
Wang, Zhongde
Tsutsumi, Takeya
Kawaoka, Yoshihiro
Ozono, Seiya
Maemura, Tadashi
Larson, Deanna
Hasegawa, Hideki
Douek, Daniel
Author_xml – sequence: 1
  givenname: Yoshihiro
  orcidid: 0000-0001-5061-8296
  surname: Kawaoka
  fullname: Kawaoka, Yoshihiro
  organization: University of Wisconsin-Madison
– sequence: 2
  givenname: Ryuta
  orcidid: 0000-0003-0890-1922
  surname: Uraki
  fullname: Uraki, Ryuta
  organization: National Center for Global Health and Medicine Research Institute
– sequence: 3
  givenname: Maki
  surname: Kiso
  fullname: Kiso, Maki
  organization: Institute of Medical Sciences, University of Tokyo
– sequence: 4
  givenname: Shun
  orcidid: 0000-0003-2258-9031
  surname: Iida
  fullname: Iida, Shun
  organization: National Institute of Infectious Diseases
– sequence: 5
  givenname: Masaki
  orcidid: 0000-0001-6988-1975
  surname: Imai
  fullname: Imai, Masaki
  organization: University of Tokyo
– sequence: 6
  givenname: Emi
  orcidid: 0000-0002-9064-4699
  surname: Takashita
  fullname: Takashita, Emi
  organization: National Institute of Infectious Diseases
– sequence: 7
  givenname: Makoto
  surname: Kuroda
  fullname: Kuroda, Makoto
  organization: University of Wisconsin at Madison
– sequence: 8
  givenname: Peter
  surname: Halfmann
  fullname: Halfmann, Peter
  organization: Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA
– sequence: 9
  givenname: Samantha
  surname: Loeber
  fullname: Loeber, Samantha
  organization: University of Wisconsin-Madison
– sequence: 10
  givenname: Tadashi
  surname: Maemura
  fullname: Maemura, Tadashi
  organization: University of Wisconsin
– sequence: 11
  givenname: Seiya
  orcidid: 0000-0001-7768-5157
  surname: Yamayoshi
  fullname: Yamayoshi, Seiya
  organization: University Of Tokyo
– sequence: 12
  givenname: Seiichiro
  surname: Fujisaki
  fullname: Fujisaki, Seiichiro
  organization: National Institute of Infectious Diseases
– sequence: 13
  givenname: Zhongde
  orcidid: 0000-0003-2441-4729
  surname: Wang
  fullname: Wang, Zhongde
  organization: Utah State University
– sequence: 14
  givenname: Mutsumi
  surname: Ito
  fullname: Ito, Mutsumi
  organization: University of Tokyo, Institute of Medical Science
– sequence: 15
  givenname: Michiko
  surname: Ujie
  fullname: Ujie, Michiko
  organization: Division of Virology, Institute of Medical Science, University of Tokyo
– sequence: 16
  givenname: Kiyoko
  orcidid: 0000-0002-8266-020X
  surname: Iwatsuki-Horimoto
  fullname: Iwatsuki-Horimoto, Kiyoko
  organization: University of Tokyo
– sequence: 17
  givenname: Yuri
  surname: Furusawa
  fullname: Furusawa, Yuri
  organization: Division of Virology, Institute of Medical Science, University of Tokyo
– sequence: 18
  givenname: Ryan
  surname: Wright
  fullname: Wright, Ryan
  organization: Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison
– sequence: 19
  givenname: Zhenlu
  surname: Chong
  fullname: Chong, Zhenlu
  organization: Washington University
– sequence: 20
  givenname: Seiya
  orcidid: 0000-0002-1764-2937
  surname: Ozono
  fullname: Ozono, Seiya
  organization: National Institute of Infectious Diseases
– sequence: 21
  givenname: Atsuhiro
  surname: Yasuhara
  fullname: Yasuhara, Atsuhiro
  organization: Division of Virology, Institute of Medical Science, University of Tokyo
– sequence: 22
  givenname: Hiroshi
  orcidid: 0000-0002-6557-0771
  surname: Ueki
  fullname: Ueki, Hiroshi
  organization: The University of Tokyo
– sequence: 23
  givenname: Yuko
  surname: Sakai
  fullname: Sakai, Yuko
  organization: Institute of Medical Sciences, University of Tokyo
– sequence: 24
  givenname: Rong
  surname: Li
  fullname: Li, Rong
  organization: Department of Animal Dairy, and Veterinary Sciences, College of Agriculture and Applied Sciences, Utah State University
– sequence: 25
  givenname: Yanan
  surname: Liu
  fullname: Liu, Yanan
  organization: Department of Animal Dairy, and Veterinary Sciences, College of Agriculture and Applied Sciences, Utah State University
– sequence: 26
  givenname: Deanna
  surname: Larson
  fullname: Larson, Deanna
  organization: Utah State University, College of Agriculture and Applied Sciences
– sequence: 27
  givenname: Michiko
  surname: Koga
  fullname: Koga, Michiko
  organization: The Institute of Medical Science, the University of Tokyo
– sequence: 28
  givenname: Takeya
  surname: Tsutsumi
  fullname: Tsutsumi, Takeya
  organization: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo
– sequence: 29
  givenname: Eisuke
  orcidid: 0000-0002-1623-873X
  surname: Adachi
  fullname: Adachi, Eisuke
  organization: The Institute of Medical Science, the University of Tokyo
– sequence: 30
  givenname: Makoto
  surname: Saito
  fullname: Saito, Makoto
  organization: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo
– sequence: 31
  givenname: Shinya
  surname: Yamamoto
  fullname: Yamamoto, Shinya
  organization: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo
– sequence: 32
  givenname: Shohei
  surname: Matsubara
  fullname: Matsubara, Shohei
  organization: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo
– sequence: 33
  givenname: Masao
  surname: Hagihara
  fullname: Hagihara, Masao
  organization: Division of Infection Control, Eiju General Hospital
– sequence: 34
  givenname: Keiko
  surname: Mitamura
  fullname: Mitamura, Keiko
  organization: Division of Infection Control, Eiju General Hospital
– sequence: 35
  givenname: Tetsuro
  surname: Sato
  fullname: Sato, Tetsuro
  organization: Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital
– sequence: 36
  givenname: Masayuki
  surname: Hojo
  fullname: Hojo, Masayuki
  organization: Department of Respiratory Medicine, National Center for Global Health and Medicine Hospital
– sequence: 37
  givenname: Shin-Ichiro
  orcidid: 0000-0002-5637-3397
  surname: Hattori
  fullname: Hattori, Shin-Ichiro
  organization: National Center for Global Health and Medicine Research Institute
– sequence: 38
  givenname: Kenji
  orcidid: 0000-0002-9424-1491
  surname: Maeda
  fullname: Maeda, Kenji
  organization: National Center For Global Health and Medicine
– sequence: 39
  givenname: Moe
  surname: Okuda
  fullname: Okuda, Moe
  organization: Department of Virology, Institute of Medical Science, University of Tokyo
– sequence: 40
  givenname: Jurika
  surname: Murakami
  fullname: Murakami, Jurika
  organization: Department of Virology, Institute of Medical Science, University of Tokyo
– sequence: 41
  givenname: Calvin
  surname: Duong
  fullname: Duong, Calvin
  organization: Department of Virology, Institute of Medical Science, University of Tokyo
– sequence: 42
  givenname: Sucheta
  surname: Godbole
  fullname: Godbole, Sucheta
  organization: Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 43
  givenname: Daniel
  surname: Douek
  fullname: Douek, Daniel
  organization: NIH
– sequence: 44
  givenname: Shinji
  surname: Watanabe
  fullname: Watanabe, Shinji
  organization: National Institute of Infectious Diseases
– sequence: 45
  givenname: Norio
  surname: Ohmagari
  fullname: Ohmagari, Norio
  organization: Disease Control and Prevention Center, National Center for Global Health and Medicine
– sequence: 46
  givenname: Hiroshi
  surname: Yotsuyanagi
  fullname: Yotsuyanagi, Hiroshi
  organization: University of Tokyo
– sequence: 47
  givenname: Michael
  orcidid: 0000-0002-8791-3165
  surname: Diamond
  fullname: Diamond, Michael
  organization: Washington University in Saint Louis
– sequence: 48
  givenname: Hideki
  surname: Hasegawa
  fullname: Hasegawa, Hideki
  organization: National Institute of Infectious Diseases
– sequence: 49
  givenname: Hiroaki
  orcidid: 0000-0001-9274-3853
  surname: Mitsuya
  fullname: Mitsuya, Hiroaki
  organization: National Center for Global Health and Medicine Research Institute
– sequence: 50
  givenname: Tadaki
  orcidid: 0000-0002-3820-9542
  surname: Suzuki
  fullname: Suzuki, Tadaki
  organization: National Institute of Infectious Diseases
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35233565$$D View this record in MEDLINE/PubMed
BookMark eNo1j1FLwzAcxIMobs59AkEKPqdN_mmS5nEWdcJg4NTXkqYpZmzNTNrB_PQWnA_HvRz3u7tBl53vLEJ3lKRAgbAsxJSlIWLKJCeKZkd6gaYgFMOcUD5B8xhdTbgEJhWl12jCODDGBZ-iZfmlgza9De5H9853ie6aUb07uqB3SRyisYfe1W7n-lPi22SzeNvg0n9iSNZ7Z4LvssdFCrfoqtW7aOdnn6GP56f3colX65fXcrHCWxjhmIFRILQFQ3JtCqUL0-hWF0XNhR0nW5MXFgB4TqUgrWGFkLWi3AJr87zhbIYe_noPwX8PNvbV1g-hG5EVSCKYUpDLMXV_Tg313jbVIbi9Dqfq_zj7BYixWnY
ContentType Journal Article
Web Resource
Copyright 2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID NPM
3V.
7XB
88I
8FK
AAFGM
ABUWG
ADZZV
AFKRA
AFLLJ
AFOLM
AGAJT
AQTIP
AZQEC
BENPR
CCPQU
COVID
DWQXO
GNUQQ
HCIFZ
M2P
PHGZM
PHGZT
PIMPY
PKEHL
PQCXX
PQEST
PQQKQ
PQUKI
PRINS
Q9U
DOI 10.21203/rs.3.rs-1375091/v1
DatabaseName PubMed
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
Science Database (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central Korea - hybrid linking
ProQuest Central (Alumni)
ProQuest Central (Alumni) - hybrid linking
ProQuest Central UK/Ireland
SciTech Premium Collection - hybrid linking
ProQuest Central Student - hybrid linking
ProQuest Central Essentials - hybrid linking
ProQuest Women's & Gender Studies - hybrid linking
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
ProQuest Central Student
SciTech Premium Collection
Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content
ProQuest One Academic Middle East (New)
ProQuest Central - hybrid linking
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
DatabaseTitle PubMed
Publicly Available Content Database
ProQuest Science Journals (Alumni Edition)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Basic
ProQuest Central Essentials
ProQuest Science Journals
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList Publicly Available Content Database
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 2693-5015
ExternalDocumentID 35233565
Genre Preprint
GroupedDBID NPM
3V.
7XB
88I
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
GNUQQ
HCIFZ
M2P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
Q9U
ID FETCH-LOGICAL-j2791-32c926ae2c04ac89a8cdafa88b56e269ec48e222541760fc3867b915e23f44d53
IEDL.DBID BENPR
IngestDate Mon Jun 30 04:24:39 EDT 2025
Wed Feb 19 02:07:57 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Japanese
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-j2791-32c926ae2c04ac89a8cdafa88b56e269ec48e222541760fc3867b915e23f44d53
Notes ObjectType-Article-1
content type line 62
ObjectType-Feature-2
SourceType-Undefined-1
ORCID 0000-0002-9064-4699
0000-0003-2441-4729
0000-0002-5637-3397
0000-0001-7768-5157
0000-0001-6988-1975
0000-0003-0890-1922
0000-0001-9274-3853
0000-0003-2258-9031
0000-0001-5061-8296
0000-0002-1764-2937
0000-0002-3820-9542
0000-0002-8791-3165
0000-0002-1623-873X
0000-0002-8266-020X
0000-0002-9424-1491
0000-0002-6557-0771
OpenAccessLink https://www.proquest.com/docview/2706399247?pq-origsite=%requestingapplication%
PMID 35233565
PQID 2706399247
PQPubID 4965281
ParticipantIDs proquest_journals_2706399247
pubmed_primary_35233565
PublicationCentury 2000
PublicationDate 2022-Feb-24
20220224
PublicationDateYYYYMMDD 2022-02-24
PublicationDate_xml – month: 02
  year: 2022
  text: 2022-Feb-24
  day: 24
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Durham
PublicationTitle Nature
PublicationTitleAlternate Res Sq
PublicationYear 2022
Publisher Research Square
Publisher_xml – name: Research Square
References 35576972 - Nature. 2022 Jul;607(7917):119-127. doi: 10.1038/s41586-022-04856-1
References_xml – reference: 35576972 - Nature. 2022 Jul;607(7917):119-127. doi: 10.1038/s41586-022-04856-1
SSID ssib057237911
Score 1.7888892
SecondaryResourceType preprint
Snippet The recent emergence of SARS-CoV-2 Omicron variants possessing large numbers of mutations has raised concerns of decreased effectiveness of current vaccines,...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
SubjectTerms Coronaviruses
COVID-19
Monoclonal antibodies
Severe acute respiratory syndrome coronavirus 2
Title Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
URI https://www.ncbi.nlm.nih.gov/pubmed/35233565
https://www.proquest.com/docview/2706399247
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG8ELsaLxi8UyQ5ey7a268fJAIEQE5CAKLel67qDkQ03MPG_t92GnvTQy0vaw2v7fq-v7_0eAPdJFAdCsQAm1MOQaI6hND4cNHfSIIJmCSrZ9qczOlmRx3WwrgNuRZ1WebCJpaGOM2Vj5C5iJZgiwh62H9B2jbK_q3ULjQZoGRPMeRO0BqPZfFHRCxmRh9286OFeXkAfl-Dofvp_O5MlqIxPwcmrjpxD_PwMHOn0HEyGPwzKVYGkY576ZtgmD7l8d4p9USailDmtX06WOMv-YgmH2QtEztPGptel7qDfQxdgNR49Dyew7nYA3xATPsRICUSlRsojUnEhuYplIjmPAqoRFVoRru3rjPiMeonCnLJI-IFGOCEkDvAlaKZZqq-BI6QXoIjq2CMxEZSZRaliGsecCiNjbdA5KCCsj2wR_iq4Da4qpYTbivEiNF4axsb1u_l_4i04RrY6wFZ8kw5o7vK9vjOYvYu69cZ0QWM2n34DAMWYCg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV09T8MwELWqMoBYQHwVCmSA0U1iO3Y8IEQLqAVaUD-gW3AcZ0CQQkJB_VP8RuykgQm2DlksxcOdfe_ZvrsHwFEcRh6XzIMxdTAkysdQaA4H9Z7UiKBYjPJu-90ebY_I1dgbV8BXWQtj0irLmJgH6mgizR25jVgOpoiw09c3aFSjzOtqKaFRLItrNfvUR7bspHOu_XuM0OXFsNWGc1UB-IQYdyFGkiMqFJIOEdLnwpeRiIXvhx5ViHIlia_MKYi4jDqxxD5lIXc9hXBMSGRUInTIXyKYOqgKlpoXvbt-0c5Io4CD7TRr4EaaQRfnYGx_uH-T1xzELtfA6oMKrfK-fh1UVLIB2q2fjs1FQaYlkkh_RlQiFc9WNs3yxJc8h3ZmTWJrcNYfwNbkHiLr9sWk8yV286yBNsFoIXbYAtVkkqgdYHHheCikKnJIRDhlelIqmcKRT7keYzVQLw0QzLdIFvw6tAa2C6MEr0WHjUCzQow11dz9_8dDsNwedm-Cm07veg-sIFOZYKrNSR1U39Op2td84T08mDvJAo-LXhff3UHS7Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+and+antiviral+susceptibility+of+SARS-CoV-2+Omicron%2FBA.2&rft.jtitle=Nature&rft.au=Kawaoka%2C+Yoshihiro&rft.au=Uraki%2C+Ryuta&rft.au=Kiso%2C+Maki&rft.au=Iida%2C+Shun&rft.date=2022-02-24&rft.pub=Research+Square&rft_id=info:doi/10.21203%2Frs.3.rs-1375091%2Fv1